ArticleNPJ Parkinson's disease2026
StimVision: smartphone video kinematics to optimize DBS programming in Parkinson's disease.
Article in NPJ Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Deep brain stimulation (DBS) improves motor function in Parkinson's disease, yet programming remains labor-intensive and largely subjective. We evaluated a smartphone video-based kinematic framework (StimVision) for objective, within-session optimization of DBS settings and characterization of therapeutic motor signatures. Fifteen patients with subthalamic DBS performed repetitive hand opening-closing while multiple stimulation programs were tested in the medication-off state. Markerless pose estimation from 60 fps smartphone video generated 23 quantitative kinematic features. A patient-specific Dynamically Weighted Improvement Score (DWIS) ranked programs by composite improvement relative to DBS-off. The framework identified a unique optimal program for each patient, with robust ranking stability. Group-level improvements at the optimal setting were dominated by gains in speed and rhythm metrics, including mean velocity, closing speed, and movement frequency, alongside reduced intra-sequence decay. Sparse principal component analysis revealed three kinematic domains-Movement Speed, Movement Consistency, and Rhythm & Timing. Structural comparison with a levodopa cohort demonstrated substantial overlap in speed and consistency domains but divergence in timing-related features. Smartphone-based kinematics enable objective DBS optimization and provide a shared quantitative framework for comparing electrical and pharmacological therapies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.